| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Sep'18 | Jun'18 |
|---|---|---|---|---|---|---|
Operating expenses | ||||||
Research and development | ||||||
9,026 | 8,541 | 8,923 | 8,859 | 7,996 | 12,538 | 6,432 |
General and administrative | ||||||
3,452 | 2,778 | 2,700 | 2,376 | 2,098 | 1,088 | 1,139 |
Total operating expenses | ||||||
12,478 | 11,319 | 11,623 | 11,235 | 10,094 | 13,626 | 7,571 |
Loss from operations | ||||||
-12,478 | -11,319 | -11,623 | -11,235 | -10,094 | -13,626 | -7,571 |
Interest income and other income (expense), net | ||||||
435 | - | - | - | 525 | - | - |
Interest income | ||||||
- | - | 654 | 573 | - | 573 | 568 |
Other income (expense), net | ||||||
- | - | - | 6 | - | 1 | 8 |
Net loss | ||||||
-12,043 | -10,781 | -10,969 | -10,656 | -9,569 | -13,052 | -6,995 |
Change in unrealized (losses) gains on marketable securities | ||||||
-65 | -13 | 41 | 29 | 39 | 16 | -6 |
Comprehensive loss | ||||||
-12,108 | -10,794 | -10,928 | -10,627 | -9,530 | -13,036 | -7,001 |
Net loss per common share, basic and diluted | ||||||
-0.59 | 7.17 | -0.54 | -1.30 | -8.69 | -13.06 | -7.47 |
Weighted average number of common shares outstanding used in computing net loss per share, basic and diluted | ||||||
20,250 | 20,510 | 20,158 | 8,218 | 1,101 | 999 | 936 |